|
Volumn 48, Issue 11, 2013, Pages 1389-1394
|
Reduced-intensity vs myeloablative conditioning allogeneic hematopoietic SCT for patients aged over 45 years with ALL in remission: A study from the adult ALL working group of the Japan Society for Hematopoietic Cell Transplantation (JSHCT)
a b c d e f g h i d j i k l m l |
Author keywords
[No Author keywords available]
|
Indexed keywords
BUSULFAN;
CYCLOPHOSPHAMIDE;
FLUDARABINE;
MELPHALAN;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ADULT;
AGED;
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION;
ARTICLE;
CANCER PROGNOSIS;
CONTROLLED STUDY;
DISEASE FREE SURVIVAL;
ENGRAFTMENT;
FEMALE;
GRAFT VERSUS HOST REACTION;
HLA MATCHING;
HUMAN;
JAPAN;
LEUKEMIA RELAPSE;
LEUKEMIA REMISSION;
MAJOR CLINICAL STUDY;
MALE;
MORTALITY;
MYELOABLATIVE CONDITIONING;
NONRELAPSE MORTALITY;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
REDUCED INTENSITY CONDITIONING;
RETROSPECTIVE STUDY;
WHOLE BODY RADIATION;
AGED;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
JAPAN;
MALE;
MIDDLE AGED;
PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;
RECURRENCE;
RETROSPECTIVE STUDIES;
TRANSPLANTATION CONDITIONING;
TRANSPLANTATION, HOMOLOGOUS;
|
EID: 84887251209
PISSN: 02683369
EISSN: 14765365
Source Type: Journal
DOI: 10.1038/bmt.2013.68 Document Type: Article |
Times cited : (31)
|
References (0)
|